0.68 - 0.75
0.33 - 0.86
12.91M / 4.66M (Avg.)
35.00 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-13.14%
Negative revenue growth while 0360.HK stands at 7.36%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-13.81%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
0.61%
Positive EBIT growth while 0360.HK is negative. John Neff might see a substantial edge in operational management.
0.61%
Positive operating income growth while 0360.HK is negative. John Neff might view this as a competitive edge in operations.
27.53%
Positive net income growth while 0360.HK is negative. John Neff might see a big relative performance advantage.
-44.39%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
3.34%
Positive diluted EPS growth while 0360.HK is negative. John Neff might view this as a strong relative advantage in controlling dilution.
129.62%
Share count expansion well above 0360.HK's 2.86%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
23.43%
Diluted share count expanding well above 0360.HK's 3.16%. Michael Burry would fear significant dilution to existing owners' stakes.
-100.00%
Dividend reduction while 0360.HK stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
114.48%
OCF growth under 50% of 0360.HK's 424.12%. Michael Burry might suspect questionable revenue recognition or rising costs.
79.98%
FCF growth similar to 0360.HK's 78.82%. Walter Schloss would attribute it to parallel capital spending and operational models.
31.83%
Positive 10Y revenue/share CAGR while 0360.HK is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
-55.08%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-50.53%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
305.97%
10Y OCF/share CAGR above 1.5x 0360.HK's 164.87%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
-9.31%
Negative 5Y OCF/share CAGR while 0360.HK is at 321.94%. Joel Greenblatt would question the firm’s operational model or cost structure.
-66.91%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-34.65%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-33.96%
Negative 5Y net income/share CAGR while 0360.HK is 68.38%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
110.85%
Positive short-term CAGR while 0360.HK is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
-3.30%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-32.09%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative 5Y dividend/share CAGR while 0360.HK stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
No Data
No Data available this quarter, please select a different quarter.
-55.41%
Firm’s AR is declining while 0360.HK shows 253.46%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
83.57%
We show growth while 0360.HK is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-17.48%
Negative asset growth while 0360.HK invests at 11.59%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-51.38%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-83.12%
We’re deleveraging while 0360.HK stands at 18.67%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-18.82%
Our R&D shrinks while 0360.HK invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-17.25%
We cut SG&A while 0360.HK invests at 25.22%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.